Reduced renal responses to nitric oxide synthase inhibition in mice lacking the gene for gp91phoxsubunit of NAD(P)H oxidase

Authors:

Abstract
Both short-term and long-term nitric oxide (NO) blockade were shown to cause an increase in O2−activity. To assess the contribution of such enhanced O2−activity in the kidney, responses to administration of the NO synthase inhibitor nitro-l-arginine methyl ester (l-NAME; 200 μg·min−1·kg body wt−1) were assessed in knockout mice the lacking NAD(P)H oxidase subunit gp91phox(KO; n = 10) and in wild-type (WT; n = 10) mice. Renal blood flow (RBF) and glomerular filtration rate (GFR) were determined by PAH and inulin clearances, respectively. Baseline RBF was higher in KO compared with WT mice (5.8 ± 0.5 vs. 4.5 ± 0.3 ml·min−1·g−1; P < 0.04) without significant differences in GFR (0.62 ± 0.04 vs. 0.73 ± 0.05 ml·min−1·g−1) and in mean arterial pressure (MAP; 91 ± 6 vs. 88 ± 4 mmHg). l-NAME infusion for 60 min caused similar increases in MAP (114 ± 6 vs. 113 ± 3 mmHg) in both groups but resulted in a lesser degree of reduction in RBF in KO compared with WT mice (−7 ± 3 vs. −17 ± 3%; P < 0.02), although GFR remained unchanged in both groups. The natriuretic response to systemic l-NAME infusion was attenuated in KO compared with WT mice (Δ: 3.1 ± 0.7 vs. 5.2 ± 0.6 μmol·min−1·g−1). l-NAME increased urinary 8-isoprostane excretion rate in WT (5.9 ± 1 to 7.7 ± 1 pg·min−1·g−1; P < 0.02) but not in KO mice (5.6 ± 1 to 4.9 ± 0.3 pg·min−1·g−1). In contrast, responses to another vasoconstrictor, norepinephrine, were similar in both strains of mice. These data indicate that activation of NAD(P)H oxidase results in the enhancement of O2−activity that influences renal hemodynamics and excretory function in the condition of NO deficiency.

This publication has 43 references indexed in Scilit: